A number of prion diseases affect humans, including Creutzfeldt-Jakob disease; most of these are due to genetic mutations in the affected individual and occur sporadically, but some result from transmission of prion proteins from external sources.
Summary
A number of prion diseases affect humans, including Creutzfeldt-Jakob disease; most of these are due to genetic mutations in the affected individual and occur sporadically, but some result from transmission of prion proteins from external sources.
Of the known animal prion diseases, only bovine spongiform encephalopathy prions have been shown to be transmissible from animals to humans under non-experimental conditions. Chronic wasting disease (CWD) is a prion disease that affects cervids (e.g., deer and elk) in North America and isolated populations in Korea and Europe. Systematic review methodology was used to identify, select, critically appraise and analyse data from relevant research. Studies were evaluated for adherence to good conduct based on their study design following the Cochrane collaboration's approach to grading the quality of evidence and the strength of recommendations (GRADE). Twenty-three studies were included after screening 800 citations from the literature search and evaluating 78 full papers. Studies examined the transmissibility of CWD prions to humans using epidemiological study design, in vitro and in vivo experiments. Five epidemiological studies, two studies on macaques and seven studies on humanized transgenic mice provided no evidence to support the possibility of transmission of CWD prions to humans. Ongoing surveillance in the United States and Canada has not documented CWD transmission to humans. However, two studies on squirrel monkeys provided evidence that transmission of CWD prions resulting in prion disease is possible in these monkeys under experimental conditions and seven in vitro experiments provided evidence that CWD prions can convert human prion protein to a misfolded state. Therefore, future discovery of CWD transmission to humans cannot be entirely ruled out on the basis of current studies, particularly in the light of possible decades-long incubation periods for CWD prions in humans. It would be prudent to continue CWD research and epidemiologic surveillance, exercise caution when handling potentially contaminated material and explore CWD management opportunities.
| INTRODUCTION
Prion diseases are rare, fatal, degenerative brain diseases that can be transmitted between individuals by a novel, infection-like mechanism involving molecular propagation of misfolded proteins known as prions (protinaceous infectious particles) (Bonda et al., 2016; Schmitz et al., 2016) . Several distinctive presentations of human prion diseases are known, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Str€ aussler-Scheinker (GSS) disease, Kuru and fatal familial insomnia (FFI) (Bonda et al., 2016; Schmitz et al., 2016) . The most common of these is CJD, which mostly occurs sporadically and likely spontaneously (Schmitz et al., 2016) . However, some cases of CJD and all cases of GSS and FFI are associated with specific genetic mutations in the human prion protein gene (PRNP) (Schmitz et al., 2016) . Human-to-human transmission of prions is quite rare and has almost always been related to inadvertent prion contamination during surgical procedures, tissue transplantation and use of humanderived biological therapies (including blood transfusions) (Bonda et al., 2016; Urwin, Mackenzie, Llewelyn, Will, & Hewitt, 2016) . Historically, one human prion disease (Kuru) was transmitted through ritual cannibalism related to tribal practices in Papua New Guinea.
A number of non-human species are also susceptible to prion diseases, including scrapie in sheep and goats, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease (CWD) in cervids (deer, elk, moose, caribou and reindeer). To date, only BSE prions have been shown to have zoonotic potential, having been transmitted to humans to cause variant Creutzfeldt-Jakob disease (vCJD) (Barron, 2014) . There is only sparse evidence bearing on the question of whether human prion disease can be caused by prions from other species.
Mitigation strategies to control prion diseases (BSE and scrapie) in domesticated animals (cattle, sheep and goats) have been effective. However, mitigation of CWD has been more challenging as it affects populations of domestic and wild cervids in North America.
CWD was first recognized in the late 1960s, although it was not confirmed to be a prion disease until 1980 (Williams, 2005) Horizontal transmission of CWD appears to readily occur via many modes, including oral and nasal routes (Haley et al., 2016) .
CWD prions can be shed in urine, faeces, saliva, blood and antler velvet in both clinical and pre-clinical-stage infections and are nearly ubiquitous throughout host tissues including skeletal muscle, fat, viscera and the central nervous system (Gough & Maddison, 2010; ). Thus, the risk of exposure to CWD prions through either direct or indirect routes is relatively high for cervids, other wild animals, hunters in direct contact with infected animals and individuals (including nonhunters) who consume venison (Saunders, Bartelt-Hunt, & Bartz, 2012) .
Research into the inter-species transmission of CWD prions has consistently noted a "species barrier" effect (defined as lower transmission efficiency compared to that within the donor species) (Beringue, Vilotte, & Laude, 2008) . Investigations into causes of the species barrier effect have identified a key influence of amino acid sequence differences in the prion protein between species (Beringue et al., 2008) . In addition, strong effects of prion "strain type" may be seen (Beringue et al., 2008 (Beringue et al., , 2012 . For prions, strain type is characterized by stable variation in properties of infection and pathogenesis such as incubation period, clinical symptoms, biochemical features of the disease-associated prion protein and patterns of prion protein deposition in the central nervous system that cannot be explained by differences in amino acid sequence (Crowell, Hughson, Caughey, & Bessen, 2015) . Both factors may apply in any given species interaction, as well as other factors such as dose, route of inoculation and age of the host (Beringue et al., 2008 (Beringue et al., , 2012 . In addition, prion agents can "adapt" to a new host species, such that initial rounds of inter-species infection do not cause disease, but the agent becomes more virulent on repeated passage (Barria, Telling, Gambetti, Mastrianni, & Soto, 2011) .
A systematic review was conducted to summarize the current evidence on the transmissibility of CWD prions to humans and identify knowledge gaps in the literature using standard systematic review methodologies (Rajic, Young, & McEwen, 2013; Sargeant, Amezcua, Rajic, & Waddell, 2005; Sargeant, Rajic, Read, & Ohlsson, 2006; Young et al., 2014) . Evidence is summarized under two subquestions related to 1) the epidemiological evidence that CWD prions from cervids are associated with prion disease in humans and 2) the evidence on CWD prion infectivity from experimental models, including genetically humanized animals (mice), non-human pri- The review team consisted of individuals with multidisciplinary expertise in epidemiology, risk assessment, microbiology, veterinary public health, knowledge synthesis and information science.
| Search strategy
To ensure the search was comprehensive, the search algorithm ("chronic wasting disease" OR CWD) AND (prion) AND ("species barrier" OR transmission OR zoonotic OR zoonoses OR transmissible OR "Creutzfeldt") was implemented in the following bibliographic databases on 5 May 2016: Scopus, PubMed/MEDLINE, Embase, CAB, Agricola and the Cochrane database. No limits were placed on the search, and it was pre-tested in Scopus.
The capacity of the electronic search to identify all relevant primary research was verified by hand searching the reference lists of 15 relevant literature reviews for additional research that had been omitted by the electronic bibliographic database search (Barron, 2014; Saunders et al., 2012; Bourne, 2015; Barria, Ironside, & Head, 2014; Gilch et al., 2011; Tranulis, Benestad, Baron, & Kretzschmar, 2011; Gill, Lane, Alibhai, Manson, & McCutcheon, 2011; Sohn HyunJoo, YoonHee, MinJeong, DongSeob, & Cho, 2011; Petchenik, 2010; Prcina, Bardon, & Kontsekova, 2008; Chakraborty, Nandi, & Jana, 2005; Kahn, Dube, Bates, & Balachandran, 2004; Miller & Williams, 2004; Salman, 2003; Bosque, 2002) . From this exercise, six potentially relevant citations were identified and added to the systematic review process. Hand searching of the following websites did not yield additional references. 
| Risk of bias, GRADE and data extraction
Full paper assessment for quality of research conduct was executed on each paper using a direct modification of the risk of bias and Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria endorsed by the Cochrane collaboration (Guyatt, Oxman, Akl et al., 2011; Higgins & Green, 2011; The GRADE, 2013 ). The risk of bias assessment aims to assess the internal validity of the study which informs one of the GRADE criteria (Higgins & Altman, 2011; Higgins & Green, 2011) . GRADE criteria are summarized across groups of like studies to indicate the level of confidence in the current evidence (The GRADE, 2013) . The one to four star grading system indicates: ****high confidence that the effect estimate is close to the true effect; ***moderate confidence in the effect estimate, but future studies may be substantially different; **limited confidence in the estimate of effect, the true effect may be substantially different; and *very little confidence in the estimate of effect, the true effect is likely to be substantially different (Balshem et al., 2011; Guyatt, Oxman, Sultan et al., 2011; Schunemann, Hill, Guyatt, Akl, & Ahmed, 2011) . The data extraction tool aimed to efficiently capture the pertinent information and results needed for meta-analysis from each study. In this review, the risk of bias and data extraction process included having one person extract the data and a second reviewer (LW) validate the extraction.
| Systematic review management and analysis
All potentially relevant citations identified by the literature search were imported into reference management software (RefWorks 2.0; ProQuest LLC, Bethesda, MD, USA), where duplicates were identified and manually removed; the list of unique citations was then imported into a web-based electronic systematic review management platform (DistillerSR, Evidence Partners, Ottawa, Canada). All stages of the systematic review were conducted within this software. Data collected by the systematic review forms were exported into Excel spreadsheets (Microsoft Corporation, Redmond, WA, USA) and analysed descriptively (frequencies and percentages) to facilitate descriptive summarization of the evidence.
| RESULTS

| Systematic review descriptive statistics
Of the 800 abstracts and titles screened for relevance, 78 were considered to report potentially relevant primary research, and the full article was obtained for confirmation of relevance. Assessment of risk of bias and data extraction was completed for 23 relevant articles published in English; one article was excluded because it was only available in Japanese, Figure 1 .
Most research was published since 2000 and originated from
North America (17/23), while the remaining studies were from prion research groups in Europe (6/23), Figure 2 and Table 1. The five epidemiological studies were based on case studies (3), a small exposed cohort (1) and a death registry (1) analysis for associations with exposure to CWD prions and developing CJD, Risk of bias is a measure of how well a study was conducted; the studies within this review were scored as low 43% or unclear 57% risk of bias, Table 1 . A ranking of "low" risk of bias indicates a study was carried out well, while an "unclear" risk of bias indicates that one or more criteria could not be assessed because the required information was not reported. In the case of the captured studies, this was mainly due to a lack of reporting concealment of the outcome assessors and/or a decrease in observations between the original sample and the number of observations reported. While these are likely reporting issues and thus would not impact the outcome, we are not provided enough information to assess whether this was properly dealt with during the experiment. In cases where prion disease was confirmed, it was determined to be genetic or sporadic; in other cases, exposure was considered probable, but there was a wide variation in the disease, Table 2 . In another study where a cohort of exposed individuals were followed for over 6 years, no CJD was documented (Olszowy et al., 2014) . No association with possible exposure to CWD prions was found by examining the Colorado state death registry (Mawhinney et al., 2006) . Thus, there is no epidemiological evidence of a link between CWD and development of CJD. Due to the study designs, the GRADE for this evidence is * out of a possible ****, indicating that future evidence may be inconsistent with the conclusions of the currently available studies.
| Transmission experiments with non-human primates or transgenic mice expressing human PrP
In to humans than squirrel monkeys. The overall GRADE of this evidence is ** meaning that we have limited confidence that the results and estimates presented here will not change with future research, which is mainly due to the limited number of studies and observations available. The two studies that challenged squirrel monkeys by both intracerebral inoculation and oral challenge successfully caused prion disease, although the incubation period was longer than observed for other prions (mink, sheep, cattle and humans) examined using the same model (Marsh, Kincaid, Bessen, & Bartz, 2005) . Given the small number of observations, the authors were unable to investigate the possible reasons why the incubation period varied, including inoculum dose, variation in prion source or species barrier effects (Marsh et al., 2005) . In two studies, macaques were challenged by intracerebral, oral and intradermal inoculations and followed for periods ranging from 1.5 to over 10 years with no indication of prion disease (Race, Meade-White, Miller et al., 2009; Race et al., 2014; Schmaedicke, 2012) . The authors hypothesize that it may take more than 10 years for macaques to develop CWD given that it takes >5 years for the macaque to develop prion disease post-inoculation with BSE prions (Schmaedicke, 2012). The prion protein (PRNP) gene sequence was compared between the macaques and squirrel monkeys in one study, which showed differences at five codon positions (56, 100, 108, 159 and 182). Of these differences, the macaques share the same codon with humans at three codon positions (56, 159 and 182) (Race et al., 2014) . Further evaluation of the significance of these differences will be needed to understand which codon or combination of codons influences resistance to CWD prion infection (Race et al., 2014) .
Seven studies investigated the transmissibility of CWD to genetically "humanized" transgenic mice, Table 4 . These are mice for which the endogenous prion protein gene had been inactivated and one or more active copies of the human prion protein gene inserted. Such transgenic mice have been shown in many studies to more closely mimic natural prion disease susceptibility patterns of the species (e.g., cattle, sheep, cervid and humans) from which the non-mouse gene originated. These experiments were conducted under controlled conditions and often had one or more negative (placebo inoculation with no prion material) or positive (CJD inoculum) control groups (Kong et al., 2005) . The low risk of bias and the consistency of the research conclusions across these studies, despite the use of different lines of transgenic mice, gives this group of studies a *** GRADE indicating that we have some confidence the overall conclusions of this research will not change with future research. In one study, the impact of creating a human-elk chimeric PrP was evaluated (Kurt et al., 2015) . The chimeric PrP was more susceptible to elk and deer CWD prions, but was concurrently less susceptible to human CJD prions (Kurt et al., 2015) . This is consistent with known determinants of inter-species prion conversion, including PrP C and PrP Sc sequence similarity and the conformation of the infectious prion. The negative transmission results reported in these seven studies support the conclusion that the transmission barrier associated with the interaction of human PrP and CWD prions is fairly strong and is stronger than the species barrier between human PrP and the BSE prion (Sandberg et al., 2010) . Table 5 , we summarize the results for the ability of CWD prions to convert human PrP. The unclear risk of bias across more than half of these studies, variation in the in vitro models and no conversion observed in 30% of the studies,
T A B L E 1 General characteristics of 23 included primary research publications
Category Count
gives this group of studies a ** GRADE indicating that we have limited confidence the overall conclusions of this research will not change with future research. These studies offer an indirect assessment of the transmissibility of CWD prions to humans as there is no direct comparison between these results and those observed with an animal model or non-experimental transmission.
There are also many other factors that influence prion infectivity, including dose, strain, routes of infection and other host specific factors (Raymond et al., 2000) . In one study, the molecular basis for CWD prion infection in humans was examined using an in vitro model of oral exposure. To do this, the in vitro model was created using enterocyte cell lines from five species including humans (Kolodziejczak et al., 2010) . The laminin receptors LRP/LR are known to be prion receptors, and using fluorescence activated cell scanning analysis, the cell surface of human enterocytes were found to have high levels of LRP/LR receptors, and in experiments, CWD prions were shown to bind to the LRP/LR receptors on the cell surface (Kolodziejczak et al., 2010) . This suggests that oral transmission of CWD prions to humans is possible, but there may be other intestinal barriers and pathways that were not studied in this experiment.
Overall, the experiments in Table 5 were mostly successful in demonstrating conversion of human PrP by CWD prions, although less efficiently than other prions and in some cases only after some protein modification by denaturation. Authors examined conversion, differences in amino acids and the conformation of the human PrP and CWD prion to explain/predict the efficiency with which a CWD prion could convert human PrP. For example, one study evaluated the effects of four single amino acid differences in the b2-a2 loop sequence segment of human PrP and found that two specific amino acids had a significant impact on the efficiency of the conversion (Kurt et al., 2015) . This may be due to changes in the conformation of the prion protein, which may be a better indicator of conversion potential than the amino acid sequence alone (Luers et al., 2013) . Thus, although several researchers have examined amino acid differences and identified that the prion protein is highly conserved between species (90%), some key differences in the amino acid sequence appear to substantially raise the energy barrier for conversion compared to others (Kurt et al., 2015) . The focus of current research on CWD transmissibility to humans is to understand the mechanisms of the species barrier between human PrP and CWD prions (Barria, Balachandran et al., 2014) . This includes a dissection of the molecular pathway from PrP C to PrP Sc to understand the molecular mechanism of the conversion and why molecular conversion occurs relatively readily between some species and less readily between others (Luers et al., 2013) . Several researchers noted that dissimilarity between PrP sequences alone does not accurately predict the transmissibility between species, and other factors are under investigation.
| DISCUSSION
One that was used in recent studies was the conformational selection model, which proposes that compatibility between the three dimensional molecular shapes of PrP Sc and PrP c are more important than the sequences of the protein backbones (Luers et al., 2013) . Current research to address this knowledge gap may improve our future understanding of the mechanisms and key features that determine the species barrier between CWD prions and human PrP, and lead to improved understanding of the risk of prion disease arising in humans as a result of CWD prion exposure.
While there is currently little evidence that CWD prions could be transmitted to humans and cause disease, researchers hypothesize that a CWD prion more readily transmissible to humans could emerge over time given sufficiently extensive human exposure (Barria, Balachandran et al., 2014) . Anyone who comes in direct contact with cervids, consumes venison or is in contact with contaminated environmental materials from CWD-affected areas could be at risk of exposure (Saunders et al., 2012) . Thus, it is also very important to understand the extent of risk for human exposure to CWD prions,
given that CWD prions are present throughout the host muscle, fat, organs, antler velvet and CNS and are excreted in many bodily fluids of infected cervids (Gough & Maddison, 2010; . Given that ongoing surveillance in the United States and Canada has not documented CWD transmission to humans, the risk is arguably low. This is further supported by the lack of evidence that CWD prions are transmissible to non-cervid species under nonexperimental conditions (Barria, Balachandran et al., 2014) . However, variation in CWD prion strains, human genetic heterogeneity, other factors contributing to individual variation, and some evidence that intraspecies and inter-species passage of CWD prions may increase the risk that CWD prions adapt to have a lower species barrier for transmission to humans, complicates this area of research (Barria et al., 2011) . Due to difficulties in diagnosing prion disease in humans, and an incubation period may last decades, if CWD transmission to humans can occur it would seem prudent to initiate preventative public health measures. Thus, in addition to continuing CWD research and epidemiologic surveillance in humans and animals, emphasis could be placed on improving our understanding of how humans are exposed to CWD prions, who is at highest risk of exposure, and initiating education and prevention strategies to minimize exposure. Such an approach would be proactive and precautionary given the current evidence and high level of uncertainty.
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DEFI NITIONS OF PRI ON ACRONYMS
PRNP, is the human gene encoding the major prion precursor protein PrP.
PrP, the protein that prions are composed, found throughout the body. 
